Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

IBIO

IBIO News

Newswire

16:21

iBio shares surge 20.62% after-hours as management unveils AI-driven long-acting antibody programs targeting obesity and cardiometabolic diseases.

13:32

iBio shares surge 20.19% intraday following credit agreement amendment with Woodforest.

13:22

iBio Common Stock Lock-Up Agreement Ends November 18, 2025

08:21

iBio Q1 Revenue Surges to $100,000, Promising Therapy IBIO-610 Showcases Long-Acting Potential, But Faces Financial Challenges

18:27

iBio Reports Q1 Loss, Shares Down 49.4% YTD

View More

About IBIO

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More